March 13, 2024
UTHealth Houston research: semaglutide reduces severity of fatty liver disease in people with HIV
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston. The use of semaglutide 1mg weekly was safe and effective in improving metabolic…
April 21, 2023
Women Faculty Forum honors four with Excellence Awards
The Women Faculty Forum at McGovern Medical School has awarded four faculty with the 2022-23 John P. and Kathrine G. McGovern Excellence Awards. The WFF Excellence Awards recognize outstanding contributions made by women faculty at the Medical School. Awards are given to…